{
    "title": "FDA panel backs Daiichi's blood thinner",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-2815045/FDA-panel-backs-Daiichis-blood-thinner.html",
    "date": "2014-10-30",
    "keywords": [
        "drug",
        "panel",
        "blood",
        "edoxaban",
        "thinner",
        "october",
        "use",
        "anticoagulant",
        "treatment",
        "johnson",
        "kidney",
        "gmt",
        "email",
        "groveroct",
        "food",
        "administration",
        "favor",
        "drugmaker",
        "factor",
        "protein",
        "role",
        "treatmentedoxaban",
        "fibrillation",
        "form",
        "condition",
        "heartbeat",
        "cause",
        "trial",
        "market",
        "monitoring",
        "restrictionsedoxaban",
        "bayer",
        "ag",
        "eliquis",
        "co",
        "pfizer",
        "inc",
        "pradaxa",
        "boehringer",
        "vote",
        "functionon",
        "staff",
        "decision",
        "subgroup",
        "mg",
        "dose",
        "warfarin",
        "functionthe",
        "fda",
        "brand",
        "name",
        "review",
        "thromboembolism",
        "vte",
        "chakrabarty",
        "paxton"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}